The prognostic value of sodium-glucose co-transporter-2 inhibitors therapy among patients with cancer and diabetes mellitus, treated with immune checkpoint inhibitors
Plasminogen activator inhibitor -1 and circulating ceruloplasmin levels in men with heart failure with preserved ejection fraction with concomitant prostate cancer
Relationship between clinical and echocardiographic outcomes and cardioprotective drugs in a population of female breast cancer patients exposed to anthracyclines